Study vs inSight AWM
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Study
Read full descriptionHide full description
这是一个由葛兰素史克(上海)医药研发公司(GSK)开发的一款致力于GSK临床试验的应用。它可以方便临床试验中的资料查看,反馈收集以及发送通知
inSight AWM
This medical platform offers advanced wound assessment and telemedicine capabilities. Utilizing computer vision, it provides rapid and accurate wound measurements for healthcare professionals. It's a CE marked and FDA registered device used globally in clinical settings and trials.
- Advanced wound assessment
- Telemedicine capabilities
- Accurate wound measurement
- Computer vision technology
- Global clinical use
- FDA registered medical device
Read full descriptionHide full description
eKare inSight is a comprehensive digital platform for wound assessment, telemedicine, and analytics. Powered by the latest advances in computer vision, inSight delivers accurate and reliable wound measurement within seconds at the point of service. Backed by robust scientific/clinical research, inSight is in use globally across the continuum of care, as well as in multi-center clinical trials. eKare inSight is a CE marked and FDA registered medical device/software. See https://ekare.ai/resource-center/publications/ for our latest publications. Copyright © 2015-2023 eKare Inc. www.ekare.ai
Screenshots
Verdict
The clearest difference is update cadence: inSight AWM at every 5 weeks against Study's every 3 months. Study's advantage is iOS requirement (12.1 vs 16.1). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Study ships an update every 3 months, inSight AWM every 5 weeks. The most recent releases landed on September 19, 2026 and October 14, 2026 respectively.
| Parameter | Study | inSight AWM |
|---|---|---|
| Price | Free | Free |
| Rating | — | 4.4 (13 ratings) — better |
| Positive reviews | — | 0.0% of reviews |
| Number of ratings | — | 13 — better |
| Update frequency | Every 3 months | Every 5 weeks — better |
| Ads | Yes | Yes |
| In-app purchases | No | No |
| Monetization | — | Ad-supported |
| Devices | iPhone, iPod — better | iPhone |
| Requires iOS | 12.1 — better | 16.1 |
| Further details — not scored | ||
| Size | 46 MB | 87 MB |
| Age rating | 17+ | 17+ |
| Developer | GlaxoSmithKline (Shanghai) Pharmaceutical R&D Co., Ltd. | e-Kare Inc |
In-app purchases
Study
No in-app purchases
inSight AWM
No in-app purchases








